The Progressive Supranuclear Palsy Clinical Deficits Scale
Objective: To develop a scale to monitor clinical deficits in patients with Progressive Supranuclear Palsy across its broad phenotypes. Background: There is currently no undisputed,…Key neuropathological features separating corticobasal degeneration from other related disorders
Objective: This study investigated the key neuropathological features that could separate corticobasal degeneration (CBD) from related parkinsonian disorders by using a decision tree algorithm. Background:…Chromogranin B in cerebrospinal fluid as a novel biomarker for Progressive supranuclear palsy
Objective: To identify the biomarker associated with progressive supranuclear palsy (PSP) for better understanding of a pathophysiology and clinical diagnosis. Background: PSP is one of…Gait initiation in patients with Progressive Supranuclear Palsy: a biomechanical and FDG-PET study
Objective: To define the brain metabolic abnormalities related to gait initiation (GI) failure in subjects with Progressive Supranuclear Palsy (PSP). Background: PSP is an atypical…Vascular Parkinsonism (VP) score: A clinical scoring system to differentiate between vascular from degenerative parkinsonism
Objective: To establish a clinical scoring system to differentiate between vascualar from degenerative parkinsonism. Background: Vascular parkinsonism (VP) constitutes (5-8) % of all parkinsonian disorders.…Temporhythmal Correction: The New Way of Therapy and Diagnostic Secondary Vascular Parkinsonism
Objective: It is known that, in vascular parkinsonism (VP) and Parkinson’s disease (PD) it is observed shortening of steps, bradikinesia, oligokinesia, gait disorders and also…Risk Factors and Subtypes of Ischemic Stroke in Patients with Parkinson’s Disease
Objective: To identify risk factors and TOAST pathogenic subtypes of ischemic stroke (IS) in patients with Parkinson's disease (PD) . Background: Several studies revealed a increased…Use of Figurative Language in Describing OFF Periods in Parkinson’s Disease
Objective: To explore the use of figurative language by individuals with Parkinson’s disease (PD) describing their experience during OFF periods. Background: OFF periods are characterized…Apomorphine as a Diagnostic tool to Identify Levodopa Responsive Atypical Parkinsonism
Objective: To assess the efficacy of apomorphine in identification of levodopa responsive atypical parkinsonism. Background: Management of atypical parkinsonism is a challenge. Most of these…Patient Characteristics, Treatment Patterns and Disease Burden in People with Parkinson’s Disease: Insights from the Parkinson’s Disease Real-World Impact Assessment (PRISM) Study
Objective: Data from the PRISM study on patient characteristics, treatment patterns and burden of disease in people with Parkinson’s disease (PwP) are presented. Background: PRISM…
Abstracts from the International Congress of Parkinson’s and Movement Disorders.